TargED Biopharmaceuticals

Utrecht, Netherlands · Founded 2018 · Privately Held (backing)

Developer of biopharmaceutical drugs intended to serve doctors and healthcare professionals to improve the treatment of thrombosis. TargED Biopharmaceuticals is based in Utrecht, Netherlands and was founded in 2018. Its last reported valuation was $50 million in Dec 2025. It has raised $72.2 million.

Last reported valuation

$50.0M

Oct 2026

Priced at

—

Total raised

$72.2M

Last round

—

How much has TargED Biopharmaceuticals raised?

$72.2Macross 0 recorded rounds

Free account

More of TargED Biopharmaceuticals with a free account

·The complete investor list: 17 names
·Watch TargED Biopharmaceuticals: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

TargED Biopharmaceuticals investors

17 investors are on record for TargED Biopharmaceuticals, including European Innovation Council, Andera Partners, Utrecht Holdings and Rotrip Europe.

For fundraisers

Raising for a company like TargED Biopharmaceuticals?

17 investors have backed TargED Biopharmaceuticals.

See all 17 investors →

Frequently asked about TargED Biopharmaceuticals

How much has TargED Biopharmaceuticals raised?: TargED Biopharmaceuticals has raised $72.2M in total across 0 recorded funding rounds.